TY - JOUR
T1 - Functional regulation of hypoxia inducible factor-1α by SET9 lysine methyltransferase
AU - Liu, Qiong
AU - Geng, Hao
AU - Xue, Changhui
AU - Beer, Tomasz M.
AU - Qian, David Z.
N1 - Funding Information:
We thank Dr. Gregg Semenza at Johns Hopkins University for providing the Hep3Bc1 cell line, and Dr. Mushui Dai at OHSU for providing expertise in protein polyubiquitination analysis and for providing U2OS cell line. This work was supported by Public Health Service grants R01CA149253 from the National Cancer Institute , W81XWH-10-1-0142 from the Department of Defense Prostate Cancer Research Program , and PNW Prostate Cancer SPORE Pilot Award , all to DZ Qian. This work was also supported by a postdoctoral training grant W81XWH-13-1-0314 from Department of Defense Prostate Cancer Research Program to Q Liu.
Publisher Copyright:
© 2015 Elsevier B.V.
PY - 2015/5/1
Y1 - 2015/5/1
N2 - HIF-1α is degraded by oxygen-dependent mechanisms but stabilized in hypoxia to form transcriptional complex HIF-1, which transactivates genes promoting cancer hallmarks. However, how HIF-1α is specifically regulated in hypoxia is poorly understood. Here, we report that the histone methyltransferase SET9 promotes HIF-1α protein stability in hypoxia and enhances HIF-1 mediated glycolytic gene transcription, thereby playing an important role in mediating cancer cell adaptation and survival to hypoxic stress. Specifically, SET9 interacts with HIF-1α and promotes HIF-1α protein stability in hypoxia. Silencing SET9 by siRNA reduces HIF-1α protein stability in hypoxia, and attenuates the hypoxic induction of HIF-1 target genes mediating hypoxic glycolysis. Mechanistically, we find that SET9 is enriched at the hypoxia response elements (HRE) within promoters of the HIF-1-responsive glycolytic genes. Silencing SET9 reduces HIF-1α levels at these HREs in hypoxia, thereby attenuating HIF-1-mediated gene transcription. Further, silencing SET9 by siRNA reduces hypoxia-induced glycolysis and inhibits cell viability of hypoxic cancer cells. Our findings suggest that SET9 enriches at HRE sites of HIF-1 responsive glycolytic genes and stabilizes HIF-1α at these sites in hypoxia, thus establishes an epigenetic mechanism of the metabolic adaptation in hypoxic cancer cells.
AB - HIF-1α is degraded by oxygen-dependent mechanisms but stabilized in hypoxia to form transcriptional complex HIF-1, which transactivates genes promoting cancer hallmarks. However, how HIF-1α is specifically regulated in hypoxia is poorly understood. Here, we report that the histone methyltransferase SET9 promotes HIF-1α protein stability in hypoxia and enhances HIF-1 mediated glycolytic gene transcription, thereby playing an important role in mediating cancer cell adaptation and survival to hypoxic stress. Specifically, SET9 interacts with HIF-1α and promotes HIF-1α protein stability in hypoxia. Silencing SET9 by siRNA reduces HIF-1α protein stability in hypoxia, and attenuates the hypoxic induction of HIF-1 target genes mediating hypoxic glycolysis. Mechanistically, we find that SET9 is enriched at the hypoxia response elements (HRE) within promoters of the HIF-1-responsive glycolytic genes. Silencing SET9 reduces HIF-1α levels at these HREs in hypoxia, thereby attenuating HIF-1-mediated gene transcription. Further, silencing SET9 by siRNA reduces hypoxia-induced glycolysis and inhibits cell viability of hypoxic cancer cells. Our findings suggest that SET9 enriches at HRE sites of HIF-1 responsive glycolytic genes and stabilizes HIF-1α at these sites in hypoxia, thus establishes an epigenetic mechanism of the metabolic adaptation in hypoxic cancer cells.
KW - Cancer
KW - Gene regulation
KW - Hypoxia
KW - Metabolic adaptation
KW - Protein interaction
KW - Transcription factor
UR - http://www.scopus.com/inward/record.url?scp=84923103681&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84923103681&partnerID=8YFLogxK
U2 - 10.1016/j.bbamcr.2015.01.011
DO - 10.1016/j.bbamcr.2015.01.011
M3 - Article
C2 - 25637186
AN - SCOPUS:84923103681
SN - 0167-4889
VL - 1853
SP - 881
EP - 891
JO - Biochimica et Biophysica Acta - Molecular Cell Research
JF - Biochimica et Biophysica Acta - Molecular Cell Research
IS - 5
ER -